Screener
Nuvectis Pharma, Inc. NVCT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055318
FAQ
- What is Nuvectis Pharma, Inc.'s net change in cash?
- Nuvectis Pharma, Inc. (NVCT) reported net change in cash of -$6.5M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s net change in cash changed year-over-year?
- Nuvectis Pharma, Inc.'s net change in cash decreased by 157.4% year-over-year, from $11.33M to -$6.5M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Nuvectis Pharma, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude